• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG AS UNIVATION XF FEMUR CEMENTED F2 RM; FEMUR IMPLANTS UNIVATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG AS UNIVATION XF FEMUR CEMENTED F2 RM; FEMUR IMPLANTS UNIVATION Back to Search Results
Model Number NO181Z
Device Problem Loosening of Implant Not Related to Bone-Ingrowth (4002)
Patient Problem Failure of Implant (1924)
Event Type  Injury  
Manufacturer Narrative
Investigation results: visual investigation: the femoral-as well as the tibial component show no device failure or serious damage.The components were examined visually and microscopically.The provided femoral component show bone cement residues on almost the whole intended area/ coated surface.This indicates that a loosening between the bone and bone cement has taken place.Batch history review: the device quality and manufacturing history records have been checked for the available lot number and were found to be according to our specifications valid at the time of production.Review of the complaint history revealed that 2 similar complaints have been filed against products from this batch number.The review of risk assessment revealed that the overall risk level (severity 4(5) x prbability 2(5) of occurrence) according to din en iso 14971 is still acceptable.Conclusion and measures / preventive measures: based upon the investigation results a clear root cause conclusion cannot be drawn.There is no indication for a material-, manufacturing- or design-related failure.Based upon the investigations results a capa is not necessary.
 
Event Description
It was reported that there was an issue with no181z - as univation xf femur cemented f2 rm.According to the complaint description, a revision surgery was necessary due to loosening of implants.Loosened and virtually no cement integration at all.A revision surgery was necessary.Additional information was not provided nor available.The adverse event is filed under aag reference (b)(4).Associated medwatch-reports: 9610612-2021-00413 ((b)(4)).9610612-2021-00288 ((b)(4)).Involved components (aufführen in d11 + c2) nl471 - univation f meniscal comp.T2 rm/lm 7mm - lot 52502902.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AS UNIVATION XF FEMUR CEMENTED F2 RM
Type of Device
FEMUR IMPLANTS UNIVATION
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
Manufacturer (Section G)
AESCULAP AG
po box 40
tuttlingen, 78501
GM   78501
Manufacturer Contact
christian von der grün
po box 40
tuttlingen, 78501
GM   78501
MDR Report Key11856129
MDR Text Key251740340
Report Number9610612-2021-00413
Device Sequence Number1
Product Code HRY
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K131167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNO181Z
Device Catalogue NumberNO181Z
Device Lot Number52518557
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/24/2021
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/29/2021
Initial Date FDA Received05/20/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/26/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NL471
Patient Outcome(s) Required Intervention;
-
-